Literature DB >> 26348614

Application of infrared-based molecular imaging to a mouse model with head and neck cancer.

Nobuaki Tanaka1,2, Shayanne A Lajud1, Andrew Ramsey1, Adam R Szymanowski1, Randall Ruffner1, Bert W O'Malley1, Daqing Li1.   

Abstract

BACKGROUND: This study investigated whether near infrared (NIR) or visible fluorescent molecular imaging produced a better representation of a mouse model with head and neck squamous cell carcinoma (HNSCC). Additionally, the study explored whether epidermal growth factor receptor (EGFR)-targeted probes could play an important role in the diagnosis of HNSCC.
METHODS: An orthotopic mouse model of HNSCC labeled with the NIR fluorophore, infrared fluorescent protein (iRFP), was developed and monitored noninvasively in real time. The tumors were further evaluated using tumor-specific EGFR-targeted probes conjugated with an NIR dye (IRDye800), or a visible fluorescent protein.
RESULTS: The iRFP cell line produced better results than cells emitting visible light when studying local, distant, and deep tumors in the mouse model. The EGFR-targeted probe conjugated with IRDye800 accurately detected tumor perimeters.
CONCLUSION: This model has great potential as a unique tool in the study of HNSCC tumor development.
© 2015 Wiley Periodicals, Inc. Head Neck 38: E1351-E1357, 2016. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  epidermal growth factor receptor (EGFR); head and neck squamous cell carcinoma (HNSCC); molecular imaging; mouse; near infrared

Mesh:

Substances:

Year:  2015        PMID: 26348614     DOI: 10.1002/hed.24226

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  AAV-iRFP labelling of human mesenchymal stem cells for near-infrared fluorescence imaging.

Authors:  Can Huang; Wenjun Lan; Feifei Wang; Chun Zhang; Xiaomei Liu; Qin Chen
Journal:  Biosci Rep       Date:  2017-04-28       Impact factor: 3.840

2.  Glycoprotein Nonmetastatic Melanoma Protein B as Potential Imaging Marker in Posttherapeutic Metastatic Head and Neck Cancer.

Authors:  Jeroen E van Schaik; Saskia H Hanemaaijer; György B Halmos; Max J H Witjes; Bernard F A M van der Laan; Bert van der Vegt; Boudewijn E C Plaat
Journal:  Otolaryngol Head Neck Surg       Date:  2020-06-30       Impact factor: 3.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.